BioWorld

Dec. 10, 1996

View Archived Issues

CUBIST PHARMACEUTICALS GETS FIRST MILESTONE IN DEAL WITH BRISTOL-MYERS

Read More

SECOND-GENERATION BACILLUS THURINGIENSIS MUTANT TOXIN BUGS BUGS BETTER

Read More

RAC RELUCTANTLY ACCEPTS VARMUS' PLAN TO REDUCE COMMITTEE'S POWER

Read More

MEDAREX TO BUY STRUGGLING HOUSTON BIOTECHNOLOGY FOR $8.6M

Read More

CELLPRO'S STEM CELL PURIFICATION SYSTEM GETS FDA APPROVAL

Read More